The External Advisory Board (EAB), composed of clinical, data science, and digital health experts not otherwise affiliated with the PCDC, works with the Scientific Advisory Committee (SAC) to share their unique experience and offer high-level strategic advice.


  • To offer insights on initiatives of the Pediatric Cancer Data Commons
  • To review and recommend strategic direction on accomplishments, goals, and collaboration opportunities for the PCDC
  • To advise the Scientific Advisory Committee

EAB Co-Chairs

Sam Blackman

Sam Blackman
Day One Biopharmaceuticals
United States

Parker Moss

Parker Moss
Genomics England
United Kingdom

EAB Members

Samuel BlackmanDay One BiopharmaceuticalsUnited States
Peggy BodinThermo FisherUnited States
Dana CallowBoston Millennia PartnersUnited States
Hubert CaronRoche GenentechFrance
Ellen ClaytonVanderbilt University School of MedicineUnited States
Jacques Demotes-MainardEuropean Clinical Research Infrastructure NetworkFrance
Joe DepaAccentureUnited States
Derek GroothuisFamily AdvocateUnited States
Nur-Ul HaqParamount GlobalUnited States
Minke HuibersGlobal HOPE InitiativeNetherlands
Parker MossExscientiaUnited Kingdom
Gregory ReamanNCI Childhood Cancer Data InitiativeUnited States
Sarah RostockPatient Advocate; St. Baldrick's FoundationUnited States
Carlos SandiParent Advocate; CTO of EKG Insights and Tangent HealthUnited States
Dominik SchneiderDortmund Municipal HospitalGermany
Greg SimonBiden Cancer InitiativeUnited States
Henry TingDelta Airlines; Emory UniversityUnited States